These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 14980541

  • 21. Combinatorial approaches to formulation development.
    Alakhov V, Pietrzynski G, Kabanov A.
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):493-501. PubMed ID: 11727314
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Process technologies for purity enhancement of large discovery libraries.
    Pottorf RS, Player MR.
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):777-83. PubMed ID: 15595438
    [Abstract] [Full Text] [Related]

  • 24. Focused combinatorial library design based on structural diversity, druglikeness and binding affinity score.
    Chen G, Zheng S, Luo X, Shen J, Zhu W, Liu H, Gui C, Zhang J, Zheng M, Puah CM, Chen K, Jiang H.
    J Comb Chem; 2005 Nov; 7(3):398-406. PubMed ID: 15877468
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Molecular conceptor for training in medicinal chemistry, drug design, and cheminformatics.
    Cohen C, Fischel O, Cohen E.
    Chem Biol Drug Des; 2007 Jan; 69(1):75-82. PubMed ID: 17313460
    [Abstract] [Full Text] [Related]

  • 28. De novo fragment design: a medicinal chemistry approach to fragment-based lead generation.
    Talamas FX, Ao-Ieong G, Brameld KA, Chin E, de Vicente J, Dunn JP, Ghate M, Giannetti AM, Harris SF, Labadie SS, Leveque V, Li J, Lui AS, McCaleb KL, Nájera I, Schoenfeld RC, Wang B, Wong A.
    J Med Chem; 2013 Apr 11; 56(7):3115-9. PubMed ID: 23509929
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Natural products and combinatorial chemistry: back to the future.
    Ortholand JY, Ganesan A.
    Curr Opin Chem Biol; 2004 Jun 11; 8(3):271-80. PubMed ID: 15183325
    [Abstract] [Full Text] [Related]

  • 33. Chemical genomics as an emerging paradigm for postgenomic drug discovery.
    Salemme FR.
    Pharmacogenomics; 2003 May 11; 4(3):257-67. PubMed ID: 12718717
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.
    Copeland RA.
    Methods Biochem Anal; 2005 May 11; 46():1-265. PubMed ID: 16350889
    [No Abstract] [Full Text] [Related]

  • 35. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 11; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 36. High-throughput X-ray crystallography for drug discovery.
    Blundell TL, Patel S.
    Curr Opin Pharmacol; 2004 Oct 11; 4(5):490-6. PubMed ID: 15351354
    [Abstract] [Full Text] [Related]

  • 37. Automated medicinal chemistry.
    Koppitz M, Eis K.
    Drug Discov Today; 2006 Jun 11; 11(11-12):561-8. PubMed ID: 16713909
    [Abstract] [Full Text] [Related]

  • 38. Receptor-assisted combinatorial chemistry: thermodynamics and kinetics in drug discovery.
    Cheeseman JD, Corbett AD, Gleason JL, Kazlauskas RJ.
    Chemistry; 2005 Mar 04; 11(6):1708-16. PubMed ID: 15565741
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Selective optimization of side activities: another way for drug discovery.
    Wermuth CG.
    J Med Chem; 2004 Mar 11; 47(6):1303-14. PubMed ID: 14998318
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.